Chronic Idiopathic Myelofibrosis Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: C43EBD2AB435EN
Market Monitor Global

Abstracts

Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively affect on the development of white blood cells (WBCs), red blood cells (RBCs) and platelets. The condition of idiopathic myelofibrosis may ultimately lead to the risk of acute myelogenous leukemia. Risk of idiopathic myelofibrosis is more in geriatric population as compared to children and adult population. Patients may develop symptoms such as weakness, weight loss, night sweats, hypertension and others. Blood chemistry tests, bone marrow aspiration, molecular testing and biopsy are useful diagnostic tools to diagnose and detect chronic idiopathic myelofibrosis. Patients with idiopathic myelofibrosis are advised to take drugs like hydroxyurea, interferon alfa, androgens, prednisone and others in order to treat this disorder. In addition, stem cell transplant and splenectomy is performed by physicians in severe cases of chronic idiopathic myelofibrosis.

This report contains market size and forecasts of Chronic Idiopathic Myelofibrosis in Global, including the following market information:

Global Chronic Idiopathic Myelofibrosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chronic Idiopathic Myelofibrosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Idiopathic Myelofibrosis include S-BIO, YM BioSciences, Sanofi and Onyx Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Idiopathic Myelofibrosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Idiopathic Myelofibrosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Idiopathic Myelofibrosis Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Biological Therapy
• Others

Global Chronic Idiopathic Myelofibrosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Idiopathic Myelofibrosis Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Research Institutes

Global Chronic Idiopathic Myelofibrosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Idiopathic Myelofibrosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Idiopathic Myelofibrosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chronic Idiopathic Myelofibrosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• S-BIO
• YM BioSciences
• Sanofi
• Onyx Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chronic Idiopathic Myelofibrosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chronic Idiopathic Myelofibrosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHRONIC IDIOPATHIC MYELOFIBROSIS OVERALL MARKET SIZE

2.1 Global Chronic Idiopathic Myelofibrosis Market Size: 2021 VS 2028
2.2 Global Chronic Idiopathic Myelofibrosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chronic Idiopathic Myelofibrosis Players in Global Market
3.2 Top Global Chronic Idiopathic Myelofibrosis Companies Ranked by Revenue
3.3 Global Chronic Idiopathic Myelofibrosis Revenue by Companies
3.4 Top 3 and Top 5 Chronic Idiopathic Myelofibrosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Idiopathic Myelofibrosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Idiopathic Myelofibrosis Players in Global Market
  3.6.1 List of Global Tier 1 Chronic Idiopathic Myelofibrosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chronic Idiopathic Myelofibrosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chronic Idiopathic Myelofibrosis Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Biological Therapy
  4.1.4 Others
4.2 By Type - Global Chronic Idiopathic Myelofibrosis Revenue & Forecasts
  4.2.1 By Type - Global Chronic Idiopathic Myelofibrosis Revenue, 2017-2022
  4.2.2 By Type - Global Chronic Idiopathic Myelofibrosis Revenue, 2023-2028
  4.2.3 By Type - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chronic Idiopathic Myelofibrosis Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Research Institutes
5.2 By Application - Global Chronic Idiopathic Myelofibrosis Revenue & Forecasts
  5.2.1 By Application - Global Chronic Idiopathic Myelofibrosis Revenue, 2017-2022
  5.2.2 By Application - Global Chronic Idiopathic Myelofibrosis Revenue, 2023-2028
  5.2.3 By Application - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chronic Idiopathic Myelofibrosis Market Size, 2021 & 2028
6.2 By Region - Global Chronic Idiopathic Myelofibrosis Revenue & Forecasts
  6.2.1 By Region - Global Chronic Idiopathic Myelofibrosis Revenue, 2017-2022
  6.2.2 By Region - Global Chronic Idiopathic Myelofibrosis Revenue, 2023-2028
  6.2.3 By Region - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chronic Idiopathic Myelofibrosis Revenue, 2017-2028
  6.3.2 US Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.3.3 Canada Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.3.4 Mexico Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chronic Idiopathic Myelofibrosis Revenue, 2017-2028
  6.4.2 Germany Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.3 France Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.4 U.K. Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.5 Italy Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.6 Russia Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.7 Nordic Countries Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.4.8 Benelux Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chronic Idiopathic Myelofibrosis Revenue, 2017-2028
  6.5.2 China Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.5.3 Japan Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.5.4 South Korea Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.5.5 Southeast Asia Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.5.6 India Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chronic Idiopathic Myelofibrosis Revenue, 2017-2028
  6.6.2 Brazil Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.6.3 Argentina Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chronic Idiopathic Myelofibrosis Revenue, 2017-2028
  6.7.2 Turkey Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.7.3 Israel Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Chronic Idiopathic Myelofibrosis Market Size, 2017-2028
  6.7.5 UAE Chronic Idiopathic Myelofibrosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 S-BIO
  7.1.1 S-BIO Corporate Summary
  7.1.2 S-BIO Business Overview
  7.1.3 S-BIO Chronic Idiopathic Myelofibrosis Major Product Offerings
  7.1.4 S-BIO Chronic Idiopathic Myelofibrosis Revenue in Global Market (2017-2022)
  7.1.5 S-BIO Key News
7.2 YM BioSciences
  7.2.1 YM BioSciences Corporate Summary
  7.2.2 YM BioSciences Business Overview
  7.2.3 YM BioSciences Chronic Idiopathic Myelofibrosis Major Product Offerings
  7.2.4 YM BioSciences Chronic Idiopathic Myelofibrosis Revenue in Global Market (2017-2022)
  7.2.5 YM BioSciences Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Chronic Idiopathic Myelofibrosis Major Product Offerings
  7.3.4 Sanofi Chronic Idiopathic Myelofibrosis Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Onyx Pharmaceuticals
  7.4.1 Onyx Pharmaceuticals Corporate Summary
  7.4.2 Onyx Pharmaceuticals Business Overview
  7.4.3 Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Major Product Offerings
  7.4.4 Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Revenue in Global Market (2017-2022)
  7.4.5 Onyx Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chronic Idiopathic Myelofibrosis Market Opportunities & Trends in Global Market
Table 2. Chronic Idiopathic Myelofibrosis Market Drivers in Global Market
Table 3. Chronic Idiopathic Myelofibrosis Market Restraints in Global Market
Table 4. Key Players of Chronic Idiopathic Myelofibrosis in Global Market
Table 5. Top Chronic Idiopathic Myelofibrosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Idiopathic Myelofibrosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Idiopathic Myelofibrosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Idiopathic Myelofibrosis Product Type
Table 9. List of Global Tier 1 Chronic Idiopathic Myelofibrosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Idiopathic Myelofibrosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Idiopathic Myelofibrosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Idiopathic Myelofibrosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Idiopathic Myelofibrosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Idiopathic Myelofibrosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2023-2028
Table 30. S-BIO Corporate Summary
Table 31. S-BIO Chronic Idiopathic Myelofibrosis Product Offerings
Table 32. S-BIO Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), (2017-2022)
Table 33. YM BioSciences Corporate Summary
Table 34. YM BioSciences Chronic Idiopathic Myelofibrosis Product Offerings
Table 35. YM BioSciences Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Chronic Idiopathic Myelofibrosis Product Offerings
Table 38. Sanofi Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), (2017-2022)
Table 39. Onyx Pharmaceuticals Corporate Summary
Table 40. Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Product Offerings
Table 41. Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Idiopathic Myelofibrosis Segment by Type in 2021
Figure 2. Chronic Idiopathic Myelofibrosis Segment by Application in 2021
Figure 3. Global Chronic Idiopathic Myelofibrosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Idiopathic Myelofibrosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Idiopathic Myelofibrosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Idiopathic Myelofibrosis Revenue in 2021
Figure 8. By Type - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 12. US Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 24. China Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Idiopathic Myelofibrosis Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Idiopathic Myelofibrosis Revenue, (US$, Mn), 2017-2028
Figure 37. S-BIO Chronic Idiopathic Myelofibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. YM BioSciences Chronic Idiopathic Myelofibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Chronic Idiopathic Myelofibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Onyx Pharmaceuticals Chronic Idiopathic Myelofibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)